Daily Stock Opinions and Ratings

Latest Stock Buy or Sell? Make More Informed Decisions!

Today, Brooke Thackray and James Hodgins commented about whether NEPT-T, FVAN-X, BTO-T, CHR-T, LXE-X, GOOS-T, AD-T, MAXR-T, MAL-T, SPP-X, MEG-T, TV-T, SIL-T, CLIQ-T, FTS-T, CPH-T, LXE-X, TGO-T, ACB-T, PXT-T, CPG-T, NTR-T, IWM-N, EMN-N, TJX-N, CTC.A-T, PPL-T, GE-N, BIR-T, NTR-T, OTEX-T, ASA-N, UPS-N, XRT-N, FHD-T, AD-T, PWF-T, POW-T, SBUX-Q, KEY-T, ZUB-T, TFII-T, ARE-T are stocks to buy or sell.

Page 3/4

WATCH

It performs well in November and December and not in January. It will set up now for a good buying opportunity at the end of January into the end of April. We are at a base of support as we come into a second period of seasonal support.

TOP PICK

From late Jan unto the end of March the stock does really well. They have a niche in the retail sector. We saw a big correction take place so it has a good opportunity. They outperform the S&P 88% of the time in the seasonal period. It is an off-price apparel company and if we get into tougher times, then consumers will have to move down market. (Analysts’ price target is $53.62)

TOP PICK

It has a strong seasonal period from late January into May and then they do poorly. It is a solid company with a 3.3% dividend and a low PE ratio. It should perform well when the trade situation calms down. (Analysts’ price target is $93.79)

TOP PICK

It got hammered. It is a seasonally strong time for small caps from the end of December into the beginning of March (7th). Tax loss selling brought it down. Revenues are focused domestically in the US.

COMMENT

2017 saw the lowest volatility and nowadays it is mean-reverting. We had 10 years of very low interest rates. When the central banks take away this liquidity, that results in a lot of volatility. Historically, when central banks pause (or reverse rates) it's scary, and central banks are doing that now. When the cycle turns (which he believes is happening now), who will buy the riskier assets out there? This worries him, referring to the October 2018 sell-off. He feels the credit cycle has tipped over, and in a year from now there'll likely be a Canadian recession, and within two years a global one. He expects more downgrades coming in the next earnings season. It's not the time to panic-sell, but when you see a rally in the market, lighten up your stocks.

COMMENT

The leading way way to play phosphates and potash in North America. He likes NTR, but because he's a mid-cap manager (and NTR is large cap) he prefers IFOS-X in this space within this cycle.

BUY

It looks cheap and the balance sheet is not distressed. He likes it here. The risk/reward is good. They have quality crude and get better pricing than its Alberta peers.

BUY

Loves it. One of his biggest holdings. It got hammered, but actually holds net cash and generates $4+/share. Incredibly cheap. They get Brent Oil pricing, another upside. It'll go back to mid-$20's.

SHORT

Not his favourite cannabis stock. They've diluted shares and are buying another company, which tells him that they're buying with stocks, not cash, which tells him that management believes their company is overvalued. ACB is very high compared to its peers. He's shorting it.

PAST TOP PICK

(A Top Pick Mar 26/18, Up 97%) They smartly bought some spectrum rights a few years ago, and now they're on the fringe of the 5G spectrum. So the value of their spectrum rights will be realized later this year. He took profits, and would be lightening up on this now as the stock does well.

PAST TOP PICK

(A Top Pick Mar 26/18, Down 30%) Also a top pick, so he'll comment there.

PAST TOP PICK

(A Top Pick Mar 26/18, Down 54%) He slightly reduced his position, but still holds it. They got into a business agreement with Sun Pharma, a bigger company, that was distributing one of the biggest drugs. They did a big promotion last year and the stock did very well, but they stopped promoting it. The inventory built up and their orders to Cipher dwindled to almost nothing. CPH stock got punished. They've since solved it with a long-term supply agreement. Also, they have two new drugs approved in 2018 with at least three more in 2019. The founder just bought a bunch of shares, which is a good sign.

BUY

It'll do well in the market he forecasts--a difficult one, and investors will bid up stable companies like Fortis that don't depend on cyclicality. OPne of his biggest holdings.

DON'T BUY

The dividend isn't safe given company turmoil. They're converting Alberta liquor stores into cannabis retail, partnering with Aurora. This is a speculative play and a logistical challenge. It's difficult to run cannabis retail when you have no product to sell. The upside is that Aurora could just vertically integrate and own the entire channel.

BUY

Precious metals will be a safe sector in the coming cycle (economic weakness). SIL has one of highest-grade silver developments in the world, and a prime takeover candidate.

Most Recent Experts

Colin Stewart

JC Clark Investments Ltd.

Stockchase Insights

5i Research

Jim Cramer - Mad Money

CNBC

Bill Harris, CFA

Avenue Investment Management

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Latest Stock Buy or Sell? Make More Informed Decisions!

Canadian Tire Corporation Ltd. (A)(CTC.A-T)

TJX Companies(TJX-N)

Eastman Chemical (EMN-N)

iShares Russell 2000 ETF(IWM-N)

A Comment -- General Comments From an Expert(A Commentary)

Nutrien Ltd.(NTR-T)

Crescent Point Energy Corp(CPG-T)

Parex Resources Inc.(PXT-T)

Aurora Cannabis(ACB-T)

TeraGo Inc.(TGO-T)

Leucrotta Exploration Inc.(LXE-X)

Cipher Pharmeuticals(CPH-T)

Fortis Inc.(FTS-T)

Alcanna(CLIQ-T)

SilverCrest Metals Inc(SIL-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Colin Stewart

Stockchase Insights

Jim Cramer - Mad Money

Bill Harris, CFA

The Panic-Proof Portfolio (Stockchase Research)